1. Home
  2. ALLR vs FOFO Comparison

ALLR vs FOFO Comparison

Compare ALLR & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$0.79

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Logo Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

FOFO

Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

SELL

Current Price

$1.52

Market Cap

15.8M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
ALLR
FOFO
Founded
2004
2017
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
15.8M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
ALLR
FOFO
Price
$0.79
$1.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 136.5K
10.2K
Earning Date
11-13-2026
12-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $320,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$11.09
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$1.58
52 Week High
$1.84
$14.93

Technical Indicators

Market Signals
Indicator
ALLR
FOFO
Relative Strength Index (RSI) 38.05 30.60
Support Level N/A N/A
Resistance Level $1.45 $1.97
Average True Range (ATR) 0.09 0.07
MACD -0.01 -0.01
Stochastic Oscillator 3.70 0.00

Price Performance

Historical Comparison
ALLR
FOFO

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About FOFO Hang Feng Technology Innovation Co. Ltd. Ordinary Shares

Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.

Share on Social Networks: